MTOR and leishmaniasis: The lack of effective vaccines and therapies for leishmaniasis along with the well-known resistance of the parasite to available agents prompted us to explore the effects of several mTOR inhibitors, including rapamycin, as potential therapeutics against Leishmania (L. ) major, the classic Leishmania parasite strain.